Molecular typing of fluoroquinolone-resistant and fluoroquinolone-susceptible Escherichia coli isolated from blood of neutropenic cancer patients in a single center

Clinical Microbiology and Infection

Volumn 5, Issue 8, 1999, Pages 457-461

  Tascini, Carlo ^a   Menichetti, Francesco ^a   Bozza, Silvia ^a   Fedele, Monica ^a   Preziosi, Roberta ^a   Allegrucci, Massimo ^a   Del Favero, Albano ^a   Micozzi, Alessandra ^b   Martino, Piero ^b   Bistoni, Francesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Escherichia coli; Fluoroquinolone resistance; Neutropenic patients; PFGE; RAPD

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CANCER PATIENT; CLINICAL ARTICLE; ESCHERICHIA COLI; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; NEUTROPENIA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; REPRODUCIBILITY;

EID: 0032831766     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00175.x     Document Type: Article

References (32)

1. Andriole VT. Quinolones. In Mandell GI, Douglas R, Bennet J, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 334-45.
2. Kern W, Kurrle E. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention or infection in patients with acute leukemia and granulocytopenia. Infection 1991; 19: 73-80.
3. The Gimema Infection Program. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Ann Intern Med 1991; 115: 7-12.
4. Acar JF, O'Brien TF, Goldstein FW, Jones RN. The epidemiology of bacterial resistance to quinolones. Drugs 1993; 45(suppl 3): 24-8.
5. Aguiar JM, Chacon J, Canton R, Baquero F. The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother 1992; 29: 349-50.
6. Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veteran Affairs medical center. Antimicrob Agents Chemother 1991; 35: 256-8.
7. Perez-Trallero E, Urbieta M, Jimenez D, Garcia-Arenzana JM, Villa G. Ten-year survey of quinolone resistance in Eschcrichia coli causing urinary tract infections. Eur J Clin Microbiol Infect Dis 1993; 12: 349-51.
8. Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofioxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991; 163: 1279-85.
9. Ogle JW, Relier LB, Vasil ML. Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe. J Infect Dis 1988; 157: 743-8.
10. Arbeit RD, Arthur M, Dunn R, Kim C, Selander RK, Goldstein R. Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis 1990; 161: 230-5.
11. Pena C, Albareda JM, Pallares R, Pujol M, Tubau F, Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995; 39: 520-4.
12. Vila J, Ruiz J, Marco F, et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of E. coli and MICs. Antimicrob Agents Chemother 1994; 38: 2477-9.
13. Carratalà J, Fernandez-Sevilla A, Tubau F, Callis M, Gudiol F. Emergence of quinolone-resistant E. coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. J Infect Dis 1995; 20: 557-60.
14. Oethinger M, Conrad S, Kaifel K, et al. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother 1996; 40: 387-92.
15. Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centre. Antimicrob Agents Chemother 1994; 38: 681-7.
16. Tenover FC, Arbeit RT, Goering VR, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
17. Bassam BJ, Caetano-Anolles G, Gresshoff PM. DNA amplification fingerprinting of bacteria. Appl Microbiol Biotechnol 1992; 38: 70-6.
18. Madico G, Akopyants NS, Berg DE. Arbitrarily primed PCR DNA fingerprinting of Escherichia coli O157:H7 strains by using templates from boiled cultures. J Clin Microbiol 1995; 33: 534-6.
19. Struelens MJ, Bax R, Deplano A, Quint WG, van Belkum A. Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting. J Clin Microbiol 1993; 31: 1964-70.
20. Tyler KD, Wang G, Tyler SD, Johnson WM. Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol 1997; 35: 339-46.
21. Van Belkum A. Amplification-based DNA fingerprinting: from artifactual to definitive typing and in between. J Clin Microbiol 1997; 35: 3008-9.
22. Farmer III JJ, Kelly MT. Enterobacteriaceae. In Balows A, Hausler JH, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 3rd edn. Washington, DC: American Society for Microbiology, 1991: 360-83.
23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 5th edn. NCCLS document M100-S5. Villanova, Pa: NCCLS, 1994.
24. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington, DC: American Society for Microbiology, 1991: 563-72.
25. Romling U, Grothues D, Heuer T, Tummler B. Physical genome analysis of bacteria. Electrophoresis 1992; 13: 626-31.
26. Berg DE, Akopyants NS, Kersulyte D. Fingerprinting microbial genomes using the RAPD or AP-PCR method. Meth Mol Cell Biol 1994; 5: 13-24.
27. Hunter P, Gaston M. Numerical index of discriminatory ability of typing system: an application of Simpson's index of diversity. J Clin Microbiol 1988; 26: 2465-6.
28. Cookson B, Johnson AP, Azadian B, et al. International inter-and intrahospital patient spread of a multiple antibiotic-resistant strain of Klebsiella pneumoniae. J Infect Dis 1995; 171: 511-13.
29. Hibbert-Rogers LCF, Heritage J, Gascoyne-Binzi DM, et al. Molecular epidemiology of ceftazidime-resistant mutants of Enterobacteriaceae from patients on a paediatric ward. J Antimicrob Chemother 1995; 36: 65-82.
30. Caetano-Anollés G. Amplifying DNA with arbitrary oligonucleotide primers. PCR Meth Appl 1993; 3: 85-94.
31. del Tuto JP, Tingey SV. RAPD assay. A novel technique in genetic diagnostic. In Isaac P, ed. Methods in molecular biology. Totowa, NJ: Humana Press Inc., 1994: 237-41.
32. Muralidharan K, Wakeland EK. Concentration of primer and template qualitatively affects products in random-amplified polymorphic DNA. PCR BioTechniques 1993; 14: 362-4.